{
  "id": "b89b72a4-0355-4bf5-9f3a-bb86be9ad36f",
  "title": "Actuate Therapeutics: Elraglusib trial meets key endpoint in pancreatic cancer",
  "link": "https://seekingalpha.com/news/4454055-actuate-therapeutics-elraglusib-trial-meets-key-endpoint-in-pancreatic-cancer?utm_source=feed_news_all\u0026utm_medium=referral\u0026feed_item_type=news",
  "description": "",
  "author": "",
  "published": "Sat, 31 May 2025 16:57:32 -0400",
  "source": "https://seekingalpha.com/market_currents.xml",
  "categories": [
    "actu"
  ],
  "byline": "Rob Williams",
  "length": 392,
  "excerpt": "Actuate Therapeutics: Elraglusib trial meets key endpoint in pancreatic cancer",
  "siteName": "Seeking Alpha",
  "favicon": "https://seekingalpha.com/samw/static/images/favicon-192x192.png",
  "text": "sasirin pamai/iStock via Getty Images Actuate Therapeutics (NASDAQ:ACTU) on Saturday announced encouraging results from a Phase 2 clinical trial testing its experimental cancer drug, elraglusib, in combination with standard chemotherapy in patients with advanced pancreatic cancer. The findings, shared Saturday at the 2025 American Society of Recommended For YouMore Trending NewsSee More »",
  "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212511704/image_2212511704.jpg?io=getty-c-w750",
  "html": "\u003cdiv id=\"readability-page-1\" class=\"page\"\u003e\u003cdiv data-test-id=\"grid-col-main\"\u003e\u003cdiv data-test-id=\"card-container\"\u003e\u003cheader\u003e\u003c/header\u003e\u003cdiv\u003e\u003cdiv data-test-id=\"content-container\"\u003e\u003cfigure contenteditable=\"false\" data-show-to-all=\"false\" data-type=\"getty-image\"\u003e\u003cpicture\u003e\u003cimg src=\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212511704/image_2212511704.jpg?io=getty-c-w750\" sizes=\"(max-width: 768px) calc(100vw - 36px), (max-width: 1024px) calc(100vw - 132px), (max-width: 1200px) calc(66.6vw - 72px), 600px\" srcset=\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212511704/image_2212511704.jpg?io=getty-c-w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212511704/image_2212511704.jpg?io=getty-c-w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212511704/image_2212511704.jpg?io=getty-c-w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212511704/image_2212511704.jpg?io=getty-c-w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212511704/image_2212511704.jpg?io=getty-c-w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212511704/image_2212511704.jpg?io=getty-c-w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212511704/image_2212511704.jpg?io=getty-c-w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212511704/image_2212511704.jpg?io=getty-c-w240 240w\" alt=\"Pancreatitis, pancreatic cancer, Asian doctor with pancreas, gallbladder and bile duct human anatomy model at hospital.\" width=\"1536px\" height=\"1024px\" data-caption=\"sasirin pamai/iStock via Getty Images\" data-id=\"2212511704\" data-image-type=\"Getty\" data-original-src=\"https://media.gettyimages.com/id/2212511704/photo/pancreatitis-pancreatic-cancer-asian-doctor-with-pancreas-gallbladder-and-bile-duct-human.jpg?b=1\u0026amp;s=612x612\u0026amp;w=0\u0026amp;k=20\u0026amp;c=tV0-n3injpSkOvosagl7CtnL2HWTikR4kfjWq77jkJ0=\" data-source=\"\" data-type=\"getty-image\"/\u003e\u003c/picture\u003e\u003cfigcaption data-type=\"getty-image\"\u003e\u003cp\u003esasirin pamai/iStock via Getty Images\u003c/p\u003e\u003c/figcaption\u003e\u003c/figure\u003e\u003carticle dir=\"auto\" data-testid=\"conversation-turn-32\" data-scroll-anchor=\"true\"\u003e\u003cdiv dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"4373658a-7226-467c-aed1-737d9d3c6503\" data-message-model-slug=\"gpt-4o\" tabindex=\"-1\"\u003e \u003cp data-start=\"123\" data-end=\"614\"\u003eActuate Therapeutics (\u003cspan\u003eNASDAQ:\u003ca title=\"Actuate Therapeutics, Inc.\" href=\"https://seekingalpha.com/symbol/ACTU\"\u003eACTU\u003c/a\u003e\u003c/span\u003e) on Saturday \u003ca title=\"announced encouraging\" href=\"https://finance.yahoo.com/news/actuate-therapeutics-presents-topline-elraglusib-203000713.html\" target=\"_blank\" rel=\"nofollow\"\u003eannounced encouraging\u003c/a\u003e results from a Phase 2 clinical trial testing its experimental cancer drug, elraglusib, in combination with standard chemotherapy in patients with advanced pancreatic cancer.\u003c/p\u003e \n\u003cp data-start=\"123\" data-end=\"614\"\u003eThe findings, shared Saturday at the 2025 American Society of\u003c/p\u003e \u003c/div\u003e\u003c/article\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv data-test-id=\"recommended-section\"\u003e\u003cdiv\u003e\u003cp\u003e\u003ch2 data-test-id=\"recommended-for-you-card-title\"\u003eRecommended For You\u003c/h2\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv data-test-id=\"post-skeleton\"\u003e\u003c/div\u003e\u003c/div\u003e\u003csection data-test-id=\"trending-card-container\"\u003e\u003cdiv\u003e\u003cdiv\u003e\u003cp\u003e\u003ch2 data-test-id=\"trending-card-title\"\u003eMore \u003cspan id=\"trending-news\"\u003eTrending News\u003c/span\u003e\u003c/h2\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv data-test-id=\"post-skeleton\"\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv\u003e\u003cp\u003e\u003ca id=\"cardFooterSeeMore\" data-test-id=\"card-footer-link\" aria-labelledby=\"trending-news cardFooterSeeMore\" href=\"https://seekingalpha.com/market-news#source=first_level_url%3Anews%7Csection%3Amain_content%7Csection_asset%3Amore_trending_news%7Cbutton%3Amore\"\u003e\u003cspan\u003eSee More »\u003c/span\u003e\u003c/a\u003e\u003c/p\u003e\u003c/div\u003e\u003c/section\u003e\u003c/div\u003e\u003c/div\u003e",
  "readingTime": "Less than 1 min",
  "publishedTime": "2025-05-31T20:57:32Z",
  "modifiedTime": null
}
